๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Factor V inhibitor in thrombosis

โœ Scribed by Ashok Kapur; Dr. Paul R. Kelsey; Peter E. T. Isaacs


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
400 KB
Volume
42
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Factor V Q 506 mutation in children with
โœ Gurgey, Aytemiz; Mesci, Lutfiye; Renda, Yavuz; Olcay, Lale; Kocak, Nurten; Erdem ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 210 KB ๐Ÿ‘ 2 views

The factor V Leiden mutation in 12-children with thrombosis and in 20 controls was investigated. Five heterozygous individuals and 1 homozygous individual among the cases with thrombosis and 1 heterozygous individual among controls were found. Central nervous system thromboses were increased in chil

A case of factor V inhibitor
โœ Lai-Lu Chong; Yuk-Cheung Wong ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 275 KB

A 57-year-old married Chinese male without a family history of bleeding disorder was presented with severe hemorrhagic tendency and was subsequently found to be suffering from an acquired inhibitor against coagulation factor V. The prolonged prothrombin time and activated partial thromboplastin time

A factor V inhibitor: In vitro interfere
โœ Macie C. Coots; Dr. Albert F. Muhleman; Helen I. Glueck ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 396 KB

## Abstract A patient with a factor V inhibitor resistant to all standard methods of therapy was recently reported. Because of this resistance, further investigation of the inhibitor was carried out employing the inhibitory plasma, serum, and isofocused fraction. It has subsequently been shown in v

Deep-vein thrombosis and coumarin skin n
โœ Kamphuisen, Pieter W.; Haan, Joost; Rosekrans, Peter C.M.; Van Der Meer, Felix J ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 17 KB

We report a 71-year-old man who developed deep-vein thrombosis after major surgery. Coumarin skin necrosis developed after starting oral anticoagulant therapy. An inhibitor to factor V (61 Bethesda units) with lupus-like features was found as well as a low protein C level. The occurrence of these ve